Skip to content
Canopy

CANOPY FOR LIFE SCIENCES

Deliver on the promise of treatment

Published at ASCO: Up to 45% potential increase in patients staying on therapy.

SYMPTOM MONITORING

In cancer, silence can be the most dangerous symptom

Unchecked symptoms lead to treatment disruptions. With Canopy, patients can report issues between visits so care teams act earlier and keep treatment on track. 

Targeted Treatment Check-Ins

Timed, tailored, multilingual outreach captures symptoms and adherence – directly from patients.

Target Treatment 2

Risk Stratification & Escalation

AI surfaces feedback to care teams and triggers appropriate outreach, helping patients get what they need – sooner.

Risk Strat 2

ENHANCED WORKFLOWS

Novel therapies require a novel approach

Modern treatments bring new complexities: stringent protocols, rigorous monitoring and other barriers to adoption. With Canopy, sponsors can provide adaptive, AI-enabled programs that help clinics deliver advanced therapies confidently.

Bispecific Therapy 2

Therapy Orchestration Modules

Native and sponsored therapy-specific workflows standardize onboarding, facilitate administration and streamline monitoring.

Care Routing 3a

Care Routing Automation

Intelligent symptom-specific triggers prioritize clinical actions, triaging follow up, and when necessary, enabling patient transfer to an advanced care facility.

Patient Education

Cancer is already overwhelming, patient education shouldn't be.

Just-in-time, symptom-specific guidance

Deliver targeted, symptom-specific information for patients at the moment it’s needed, reducing confusion, mis-steps and empowering effective self-care.

Dynamic education modules

AI-driven education delivers personalized, cross-journey support — helping each patient understand their therapy plan, anticipate what’s next, and stay adherent throughout treatment.

Just-in-time, symptom-specific guidance

Deliver targeted, symptom-specific information for patients at the moment it’s needed, reducing confusion, mis-steps and empowering effective self-care.

Dynamic education modules

AI-driven education delivers personalized, cross-journey support — helping each patient understand their therapy plan, anticipate what’s next, and stay adherent throughout treatment.

Partner with Canopy

Life Science partners collaborate with Canopy’s oncology network to help patients navigate symptoms, stay adherent, and realize the full benefit of therapy.

Learn more

OUR RESEARCH

Publications

American Society of Clinical Oncology Annual Meeting

2025

Application of the remote therapeutic monitoring (RTM) platform to optimize adherence and manage toxicity of oral anti-cancer medications.

Sharma S, Doshi G, Hughes L, Kolodziej MA, Kwiatkowsky L, Calkins G, Ascha MS.

Journal of Clinical Pathways

2025

Remote therapeutic monitoring to support adoption of bispecific antibody therapy in community practices.

Essell JH, Derman BA, Brooks B, Doshi GK, Kolodziej MA, Kwiatkowsky L, Calkins G, Ascha MS.

American Society of Clinical Oncology Annual Meeting

2025

Electronic patient reported outcomes in breast cancer patients receiving adjuvant chemotherapy with doxorubicin/cyclophosphamide combined with paclitaxel compared to patients receiving docetaxel/cyclophosphamide.

Kolodziej MA, Ascha M, Blau S, Schaefer ES, Telivala B, Calkins G, Neiman J, Kwiatkowsky L, Essell JH, Derman B, Patt D.

American Society of Clinical Oncology Annual Meeting

2025

Electronic patient-reported outcomes (ePRO) in patients with advanced melanoma receiving immune checkpoint inhibitors: Insights from the Canopy ePRO system.

Derman B, Ascha M, Essell JH, Kwiatkowsky L, Calkins G, Neiman J, Kolodziej MA.

American Society of Hematology Annual Meeting

2024

Electronic patient-reported outcome (ePRO) symptom monitoring for relapsed/refractory multiple myeloma in community settings, focusing on bispecific antibody therapy.

Derman BA, Essell JH, Kolodziej MA, Kwiatkowsky L, Calkins G, Parrinello CM, Ascha MS.